Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma

In metastatic renal cell carcinoma, complete response to first-line antiangiogenic agents is rare and resistance to therapy often develops. Protocols for sequential treatment with angiogenesis and mTOR inhibitors are under evaluation to improve outcomes. In this observational, real-world study, pati...

Descrición completa

Detalles Bibliográficos

Principais autores:	Sabrina Rossetti, Carmine D'Aniello, Gelsomina Iovane, Sarah Scagliarini, Maria M. Laterza, Fernando De Vita, Clementina Savastano, Giacomo Cartenì, Maria A. Porricelli, Massimiliano Berretta, Salvatore Pisconti, Gaetano Facchini, Carla Cavaliere
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2017-07-01
Series:	Frontiers in Pharmacology
Assuntos:	metastatic renal carcinoma pazopanib everolimus sequential therapy real-world
Acceso en liña:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00484/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!